Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis is primarily a neurodegenerative disease.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Statins in neurological disorders: An overview and update.
Natalizumab and fingolimod: Insight into their relative efficacies in clinical practice.
Risk stratification and mitigation in multiple sclerosis.
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
Exercise and cognition in multiple sclerosis: The importance of acute exercise for developing better interventions.
Acute Disseminated Encephalomyelitis After Plasmodium Vivax Infection: Case Report and Review of Literature.
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Association of smoking with risk of multiple sclerosis: a population-based study.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm.
Relevance of Spinal Cord Abnormalities to Clinical Disability in Multiple Sclerosis: MR Imaging Findings in a Large Cohort of Patients.
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
New immunological approaches in treating and diagnosing CNS diseases.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.

Pages